LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
P/E ratio for LifeStance Health Group, Inc. (LFST)
P/E ratio as of 2023: -15.45
According to LifeStance Health Group, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -15.45. At the end of 2022 the company had a P/E ratio of -8.14.
P/E ratio history for LifeStance Health Group, Inc. from 2019 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -15.45 |
| 2022 | -8.14 |
| 2021 | -10.15 |
| 2020 | -214.94 |
| 2019 | 1443.45 |